I doubt we will see big, sustained rises off approvals alone. The HCV WHO approval came at a time when COVID sentiment was really driving prices forwards. Wouldn’t surprise me if people jumped in then thinking the news was related to COVID. On top of that CE Marking had no lasting impact.
I would have thought that if a test was validated, that the ICMR would just list it, I doubt they would wait for a company to release an RNS first. Guess it also depends whether or not today's update includes tests validated today or not.
RE: Temporary Regulatory Affairs Officer @ Genedrive25 Jun 2020 16:25
Mavern, that statement alone shows that your approach to reaching conclusions is severely flawed. Taking some moments to check out my post history would save you from making the same mistake in future.
If you are so weak minded and insecure in your investment, that posts that explore all possibilities cause you to react like this then I suggest you don't use discussion forums. Leave it to the adults.
RE: Temporary Regulatory Affairs Officer @ Genedrive25 Jun 2020 16:21
I am actually edging towards it being a positive thing to be honest.
If there isn't an update on approvals within the next week or so I would start to get a little concerned but the fact that DB isn't as 'chatty' as the AVCT CEO for example doesn't really concern me. Shareholders care more about a steady flow of news than CEO's, as they usually have a much longer term view in terms of the share price.
RE: Temporary Regulatory Affairs Officer @ Genedrive25 Jun 2020 16:05
Support is a pretty broad term when it comes to role descriptions. Take the following scenario.
They have failed to get any interest in the product in their target markets, so they decide that they need to seek other opportunities as quickly as possible. They take on an extra person so they now have additional resource dealing with approvals, resulting in them being done twice as fast, hopefully increasing the chance of getting sales.
Tell me how you can completely rule out the above scenario?
Spoiler alert: You can't rule it out.
I am not saying that I think they are doing this for negative reasons, I am saying that I am open minded enough to know that this is not a slam dunk positive.
RE: Temporary Regulatory Affairs Officer @ Genedrive25 Jun 2020 15:31
It's difficult to judge either way really.
It could be positive in that due to the fact that they are getting plenty of potential orders that they need somebody to keep approvals moving while others are dealing with orders. It could be negative in that due to the fact that the target markets are not going as planned, they need to speed up approvals elsewhere to try and get more orders in.
I don't really see how the temporary nature of the role is seen as a negative. Regardless of the reasons for the role, it makes sense to me that it would be temporary.
Honestly, I can't really say exactly as it depends on the state of the other markets. I can't see myself selling out at anything less than £2.50 if I am honest and I think there is a decent chance of it at least spiking to that sort of level on some good sales news. After that, it would really just be a case of balancing the state of GDR with the other opportunities out there.